<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02289157</url>
  </required_header>
  <id_info>
    <org_study_id>STU 042014-047</org_study_id>
    <nct_id>NCT02289157</nct_id>
  </id_info>
  <brief_title>Negative Pressure Wound Therapy in Cesarean Section</brief_title>
  <acronym>NPWTCS</acronym>
  <official_title>Negative Pressure Wound Therapy in High Risk Patients Undergoing Cesarean</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>KCI USA, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Texas Southwestern Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators propose a prospective, randomized trial evaluating the use of negative
      pressure wound therapy (NPWT) with high risk obstetrical patients. The investigators
      hypothesize that negative pressure wound therapy will decrease the wound complications in
      these patients. The investigators aim to look at all wound complications such as infection
      and disruption and will be using Prevena incision management system for our NPWT device .
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a prospective, randomized, controlled trial of pregnant women who present for
      prenatal care at Parkland Health and Hospital System. The participants will be limited to
      women undergoing a cesarean section who are high risk for wound complications: all patients
      with a BMI &gt; 40 undergoing cesarean section.

      The primary outcome will be wound complication defined as wound disruption or wound
      infection. A wound disruption will be defined as the partial or complete opening of the deep
      subcutaneous space, not to include superficial skin separation. Underlying causes will
      include seroma, hematoma, abscess, and facial dehiscence. Wound infection will be defined as
      a physician diagnosis of wound infection with erythema and warmth extending beyond the
      immediate area adjacent to the incision and requiring treatment with antibiotics.

      All patients with a BMI &gt; 40 undergoing scheduled cesarean section and patients with a BMI
      &gt;40 who are admitted in labor will be approached to participate in the study. If patients
      meeting this criteria undergo cesarean section, they will be randomized to negative pressure
      wound therapy or a standard dressing. All labor treatment, pre-operative antibiotics,
      surgical technique, and post-operative care will not differ from current standard of care.
      All patients randomized will be included in the study.

      All study participants will have the thickness of their subcutaneous tissue measured with a
      sterile ruler. Patients randomized to NPWT will have a negative pressure wound therapy system
      placed over her incision per the manufacturer's protocol. All patients randomized to standard
      dressing will have the customary dressing of gauze and surgical tape placed over her
      incision.

      The investigators will be utilizing a single use negative pressure wound therapy system for
      the study. Single use negative pressure wound therapy systems are composed of a pressure pump
      and dressing kit. The pump creates a negative pressure of 125 mmHg (+/- 20 mgHg) and the
      dressing directly covers surgical incision. The system is battery-powered and designed to be
      used for a minimum of two days and a maximum of seven days of continuous use.

      All randomized patients will undergo an examination of their incision by a research physician
      or nurse prior to discharge. The NPWT will be removed prior to discharge or on post-operative
      day seven, whichever comes first. All postpartum patients who undergo a cesarean delivery are
      inpatients until at least post-operative day three and will continue use of NPWT until day of
      discharge. In patients randomized to a standard dressing, the dressing will be removed prior
      to discharge per current standard of care.

      All randomized patients will also undergo a 2 week post-operative incisional examination by a
      research physician or nurse at the obstetrical complications clinic. Patients will be
      followed until 30 days postpartum for any wound complications to include wound infection
      (superficial and deep), readmission to the hospital, re-operation for wound complications,
      hematoma, seroma, dehiscence, superficial infection requiring antibiotics, or additional
      clinical evaluations for wound care in the emergency room or clinic setting. A research
      physician or nurse will contact each after at least 30 days post-operative to confirm the
      patients' status and ensure no evaluations, admissions, or interventions were done at outside
      facilities.

      Subjects will exit the study if they are unable to complete the post-operative visit or
      withdrawal consent for participation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 27, 2015</start_date>
  <completion_date type="Actual">October 21, 2016</completion_date>
  <primary_completion_date type="Actual">August 30, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized Placebo Controlled Clinical Trial - Open Label</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Wound Complication</measure>
    <time_frame>Day of surgery to 30 days postoperative</time_frame>
    <description>Number of Patients with Wound infection complications: hematoma, seroma, dehiscence, or Surgical Site Infection.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Classification of Wound Morbidity</measure>
    <time_frame>Day of Surgery to 30 days postoperative</time_frame>
    <description>Listing of different types of wound morbidity in the 2 cohorts: dehiscence, cellulitis, superficial SSI, deep SSI, organ space SSI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of Postoperative Stay</measure>
    <time_frame>Length of Postoperative Stay</time_frame>
    <description>Number of Days in Hospital after Initial Surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Stay After Readmission</measure>
    <time_frame>After dismissal and readmitted within 30 days for wound morbidity</time_frame>
    <description>Number of days in hospital after readmission for wound morbidity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients With Emergency Room Visits After Discharge</measure>
    <time_frame>Day of surgery to 30 days postoperative</time_frame>
    <description>Number of emergency room visits made after initial discharge by the study (icNPT) and comparison groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients With Number of Clinic Visits</measure>
    <time_frame>Day of surgery to 30 days postoperative</time_frame>
    <description>Number of clinic visits made by patients after surgery concerning wound morbidity per patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Morbid Outcomes After Delivery</measure>
    <time_frame>Day of Surgery to 30 days postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Scheduled and Unscheduled Cesarean Section</measure>
    <time_frame>Day of Surgery to 30 days postoperative</time_frame>
    <description>Cochran Mantel-Hanzel measures used to compare interactions between scheduled and unscheduled cesarean sections stratified by icNPT and standard dressing, for wound morbidity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Pfannenstiel Versus Midline Abdominal Incisions for Cesarian Section</measure>
    <time_frame>Day of Surgery to 30 days postoperative</time_frame>
    <description>Cochran-Mantel-Haenzel test for interactions between pfannenstiel and midline abdominal incisions stratified by icNPT vs Standard dressing, for wound morbidity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients With Ruptured and Unruptured Membranes Prior to Cesarean Section</measure>
    <time_frame>Day of Surgery to 30 days postoperative</time_frame>
    <description>Cochran-Mantel-Haenzel measure used to compare interaction in icNPT and Standard dressing stratified by Ruptured vs Unruptured membranes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients in Labor Versus no Labor Prior to Cesarean Section</measure>
    <time_frame>Day of Surgery to 30 days postoperative</time_frame>
    <description>Cochran-Mantel-Haenzel measure used to compare interaction in icNPT and Standard dressing stratified by patients in labor and patients not in labor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients With Hypertension Versus no Hypertension</measure>
    <time_frame>Day of Surgery to 30 days postoperative</time_frame>
    <description>Cochran-Mantel-Haenzel measure used to compare interaction between patients with hypertension versus no hypertension stratified by icNPT versus standard dressing, in wound morbidity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients With Insulin Requiring Diabetes Versus no Insulin Requiring Diabetes</measure>
    <time_frame>Day of Surgery to 30 days postoperative</time_frame>
    <description>Cochran-Mantel-Haenzel measure used to compare interaction in icNPT and Standard wound dressings stratified by women with insulin requiring diabetes and no insulin requiring Diabetes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients With Chorioamnionitis Versus no Chorioamnionitis</measure>
    <time_frame>Day of Surgery to 30 days postoperative</time_frame>
    <description>Cochran-Mantel-Haenzel measure used to estimate interaction between chorioamnionitis and no chorioamnionitis stratified by icNPT and standard dressing, for wound morbidity</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">441</enrollment>
  <condition>Postoperative Wound Complications</condition>
  <arm_group>
    <arm_group_label>Negative Pressure Wound Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After standard cesarean section completed patients will have Prevena negative pressure wound therapy system placed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard dressing</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>After standard cesarean section completed patients will have standard dressing placed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Negative pressure wound therapy</intervention_name>
    <description>Single use negative pressure wound therapy systems are composed of a pressure pump and dressing kit. The pump creates a negative pressure of 125 mmHg (+/- 20 mgHg) and the dressing directly covers surgical incision. The system is battery-powered and designed to be used for a minimum of two days and a maximum of seven days of continuous use. The investigators hypothesize that negative pressure wound therapy will decrease the wound complications in these patients. The investigators will be using Prevena Incision Management System as the negative pressure device in our study.</description>
    <arm_group_label>Negative Pressure Wound Therapy</arm_group_label>
    <other_name>Prevena</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women with BMI &gt; 40 undergoing a cesarean delivery at Parkland Health and
             Hospital System.

        Exclusion Criteria:

          -  Any patient not meeting inclusion criteria will be deemed ineligible.

          -  All HIV positive patients will be excluded due to the increased risk of infectious
             complications in these patients.

          -  Although patients on anticoagulants can use NPWT, they will be excluded as there may
             be an increased risk of bleeding in these patients.

          -  according to the wound therapy manufacturer's instructions patients with:

               -  fragile skin

               -  allergy to silver or acrylic adhesives

               -  a malignancy in the wound bed or margins of the wound bed

               -  non-enteric and unexplored fistulas

               -  necrotic tissue with eschar present

               -  exposed arteries, veins, nerves or organs, anastomotic sites, or surgical suction
                  are not candidates for usage of the device.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Scott Roberts, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UT Southwestern Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Parkland Memorial Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <study_first_submitted>October 6, 2014</study_first_submitted>
  <study_first_submitted_qc>November 7, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 13, 2014</study_first_posted>
  <results_first_submitted>April 11, 2018</results_first_submitted>
  <results_first_submitted_qc>May 31, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">July 2, 2018</results_first_posted>
  <last_update_submitted>May 31, 2018</last_update_submitted>
  <last_update_submitted_qc>May 31, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients recruited in the Parkland Hospital Maternal-Fetal Medicine High Risk Clinic, on the Antepartum Floor, in Labor and Delivery, and in the preoperative holding area. January 2015 until July 2016. 850 screened. See Figure 1 Flow Diagram.</recruitment_details>
      <pre_assignment_details>Patients were excluded for pre-specified exclusion criteria and if they delivered vaginally after consent was obtained. 850 patients were screened. 173 declined participation, 5 withdrew consent, 2 delivered at outside facility, 211 delivered vaginally, 10 did not meet inclusion criteria, and 8 not identified to be enrolled.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Negative Pressure Wound Therapy</title>
          <description>After standard cesarean section completed patients will have Prevena negative pressure wound therapy system placed.
Negative pressure wound therapy: Single use negative pressure wound therapy systems are composed of a pressure pump and dressing kit. The pump creates a negative pressure of 125 mmHg (+/- 20 mgHg) and the dressing directly covers surgical incision. The system is battery-powered and designed to be used for a minimum of two days and a maximum of seven days of continuous use. The investigators hypothesize that negative pressure wound therapy will decrease the wound complications in these patients. The investigators will be using Prevena Incision Management System as the negative pressure device in our study.</description>
        </group>
        <group group_id="P2">
          <title>Standard Dressing</title>
          <description>After standard cesarean section completed patients will have standard dressing placed.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="222"/>
                <participants group_id="P2" count="219"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>No Post op Check or Follow up Phone Call</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="222"/>
                <participants group_id="P2" count="219"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Negative Pressure Wound Therapy</title>
          <description>After standard cesarean section completed patients will have Prevena negative pressure wound therapy system placed.
Negative pressure wound therapy: Single use negative pressure wound therapy systems are composed of a pressure pump and dressing kit. The pump creates a negative pressure of 125 mmHg (+/- 20 mgHg) and the dressing directly covers surgical incision. The system is battery-powered and designed to be used for a minimum of two days and a maximum of seven days of continuous use. The investigators hypothesize that negative pressure wound therapy will decrease the wound complications in these patients. The investigators will be using Prevena Incision Management System as the negative pressure device in our study.</description>
        </group>
        <group group_id="B2">
          <title>Standard Dressing</title>
          <description>After standard cesarean section completed patients will have standard dressing placed.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="222"/>
            <count group_id="B2" value="219"/>
            <count group_id="B3" value="441"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.1" spread="6.1"/>
                    <measurement group_id="B2" value="30.3" spread="6.1"/>
                    <measurement group_id="B3" value="29.7" spread="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="222"/>
                    <measurement group_id="B2" value="219"/>
                    <measurement group_id="B3" value="441"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Race Black</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56"/>
                    <measurement group_id="B2" value="60"/>
                    <measurement group_id="B3" value="116"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Race Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="151"/>
                    <measurement group_id="B2" value="146"/>
                    <measurement group_id="B3" value="297"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Race White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gestational age at delivery</title>
          <units>weeks</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38.6" spread="1.9"/>
                    <measurement group_id="B2" value="38.7" spread="4.5"/>
                    <measurement group_id="B3" value="38.6" spread="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Parity</title>
          <description>Number of deliveries after 20 weeks prior to the present delivery</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Parity 0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Parity 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64"/>
                    <measurement group_id="B2" value="68"/>
                    <measurement group_id="B3" value="132"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Parity 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62"/>
                    <measurement group_id="B2" value="57"/>
                    <measurement group_id="B3" value="119"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Parity &gt; 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41"/>
                    <measurement group_id="B2" value="52"/>
                    <measurement group_id="B3" value="93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI at Delivery</title>
          <units>BMI = kg/meter^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46.6" spread="6.0"/>
                    <measurement group_id="B2" value="45.8" spread="5.8"/>
                    <measurement group_id="B3" value="46.3" spread="6.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Tobacco use</title>
          <description>Number of smokers in each arm numbers</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Chronic hypertension</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="36"/>
                    <measurement group_id="B3" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Insulin Requiring Diabetes</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Primary Cesarean</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="95"/>
                    <measurement group_id="B2" value="80"/>
                    <measurement group_id="B3" value="175"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cesarean Priority</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Scheduled</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="72"/>
                    <measurement group_id="B2" value="72"/>
                    <measurement group_id="B3" value="144"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ASAP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="141"/>
                    <measurement group_id="B2" value="138"/>
                    <measurement group_id="B3" value="279"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Emergent</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Length of Surgery</title>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="84" lower_limit="70" upper_limit="103"/>
                    <measurement group_id="B2" value="80" lower_limit="64" upper_limit="99"/>
                    <measurement group_id="B3" value="82" lower_limit="67" upper_limit="101"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Estimated blood loss</title>
          <units>ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1181" spread="294"/>
                    <measurement group_id="B2" value="1136" spread="285"/>
                    <measurement group_id="B3" value="1159" spread="291"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Midline skin incision</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="170"/>
                    <measurement group_id="B2" value="158"/>
                    <measurement group_id="B3" value="328"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Suture skin closure</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="210"/>
                    <measurement group_id="B2" value="211"/>
                    <measurement group_id="B3" value="421"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Subcutaneous skin depth in cm</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.5" spread="1.3"/>
                    <measurement group_id="B2" value="5.3" spread="1.8"/>
                    <measurement group_id="B3" value="5.4" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number subcutaneous layers closed</title>
          <units>layers</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3" lower_limit="2" upper_limit="4"/>
                    <measurement group_id="B2" value="3" lower_limit="2" upper_limit="4"/>
                    <measurement group_id="B3" value="3" lower_limit="2" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Incision length in cm</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14.5" spread="2.5"/>
                    <measurement group_id="B2" value="14.6" spread="2.9"/>
                    <measurement group_id="B3" value="14.6" spread="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Patients in labor prior cesarean</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Induction Labor</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ruptured Membranes</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="77"/>
                    <measurement group_id="B2" value="59"/>
                    <measurement group_id="B3" value="136"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Chorioamnionitis</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Wound Complication</title>
        <description>Number of Patients with Wound infection complications: hematoma, seroma, dehiscence, or Surgical Site Infection.</description>
        <time_frame>Day of surgery to 30 days postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Negative Pressure Wound Therapy</title>
            <description>After standard cesarean section completed patients will have Prevena negative pressure wound therapy system placed.
Negative pressure wound therapy: Single use negative pressure wound therapy systems are composed of a pressure pump and dressing kit. The pump creates a negative pressure of 125 mmHg (+/- 20 mgHg) and the dressing directly covers surgical incision. The system is battery-powered and designed to be used for a minimum of two days and a maximum of seven days of continuous use. The investigators hypothesize that negative pressure wound therapy will decrease the wound complications in these patients. The investigators will be using Prevena Incision Management System as the negative pressure device in our study.</description>
          </group>
          <group group_id="O2">
            <title>Standard Dressing</title>
            <description>After standard cesarean section completed patients will have standard dressing placed.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Wound Complication</title>
          <description>Number of Patients with Wound infection complications: hematoma, seroma, dehiscence, or Surgical Site Infection.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="222"/>
                <count group_id="O2" value="219"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37"/>
                    <measurement group_id="O2" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.54</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Ho: There is no difference between number of patients with wound complications between the study (icNPT) and comparison groups.</method_desc>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.5</ci_lower_limit>
            <ci_upper_limit>1.4</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Classification of Wound Morbidity</title>
        <description>Listing of different types of wound morbidity in the 2 cohorts: dehiscence, cellulitis, superficial SSI, deep SSI, organ space SSI</description>
        <time_frame>Day of Surgery to 30 days postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Negative Pressure Wound Therapy</title>
            <description>After standard cesarean section completed patients will have Prevena negative pressure wound therapy system placed.
Negative pressure wound therapy: Single use negative pressure wound therapy systems are composed of a pressure pump and dressing kit. The pump creates a negative pressure of 125 mmHg (+/- 20 mgHg) and the dressing directly covers surgical incision. The system is battery-powered and designed to be used for a minimum of two days and a maximum of seven days of continuous use. The investigators hypothesize that negative pressure wound therapy will decrease the wound complications in these patients. The investigators will be using Prevena Incision Management System as the negative pressure device in our study.</description>
          </group>
          <group group_id="O2">
            <title>Standard Dressing</title>
            <description>After standard cesarean section completed patients will have standard dressing placed.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Classification of Wound Morbidity</title>
          <description>Listing of different types of wound morbidity in the 2 cohorts: dehiscence, cellulitis, superficial SSI, deep SSI, organ space SSI</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="222"/>
                <count group_id="O2" value="219"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Dehiscence</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cellulitis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Superficial incisional SSI</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                    <measurement group_id="O2" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Deep incisional SSI</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Organ space infection</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Ho: There is no difference between the types wound morbidity in the study (icNPT) and comparison groups.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.31</p_value>
            <method>Chi-squared</method>
            <method_desc>Pearson Chi-squared, df (3)</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Postoperative Stay</title>
        <description>Number of Days in Hospital after Initial Surgery</description>
        <time_frame>Length of Postoperative Stay</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Negative Pressure Wound Therapy</title>
            <description>After standard cesarean section completed patients will have Prevena negative pressure wound therapy system placed.
Negative pressure wound therapy: Single use negative pressure wound therapy systems are composed of a pressure pump and dressing kit. The pump creates a negative pressure of 125 mmHg (+/- 20 mgHg) and the dressing directly covers surgical incision. The system is battery-powered and designed to be used for a minimum of two days and a maximum of seven days of continuous use. The investigators hypothesize that negative pressure wound therapy will decrease the wound complications in these patients. The investigators will be using Prevena Incision Management System as the negative pressure device in our study.</description>
          </group>
          <group group_id="O2">
            <title>Standard Dressing</title>
            <description>After standard cesarean section completed patients will have standard dressing placed.</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Postoperative Stay</title>
          <description>Number of Days in Hospital after Initial Surgery</description>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="222"/>
                <count group_id="O2" value="219"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="3" upper_limit="4"/>
                    <measurement group_id="O2" value="3" lower_limit="3" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.54</p_value>
            <p_value_desc>Ho: There is no difference between initial length of stay between the study (icNPT) and comparison groups.</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Stay After Readmission</title>
        <description>Number of days in hospital after readmission for wound morbidity</description>
        <time_frame>After dismissal and readmitted within 30 days for wound morbidity</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Negative Pressure Wound Therapy</title>
            <description>After standard cesarean section completed patients will have Prevena negative pressure wound therapy system placed.
Negative pressure wound therapy: Single use negative pressure wound therapy systems are composed of a pressure pump and dressing kit. The pump creates a negative pressure of 125 mmHg (+/- 20 mgHg) and the dressing directly covers surgical incision. The system is battery-powered and designed to be used for a minimum of two days and a maximum of seven days of continuous use. The investigators hypothesize that negative pressure wound therapy will decrease the wound complications in these patients. The investigators will be using Prevena Incision Management System as the negative pressure device in our study.</description>
          </group>
          <group group_id="O2">
            <title>Standard Dressing</title>
            <description>After standard cesarean section completed patients will have standard dressing placed.</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Stay After Readmission</title>
          <description>Number of days in hospital after readmission for wound morbidity</description>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="222"/>
                <count group_id="O2" value="219"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16" lower_limit="6" upper_limit="22"/>
                    <measurement group_id="O2" value="21" lower_limit="11" upper_limit="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Ho: There is no difference in length of stay after readmission for wound morbidity between the study (icNPT) and comparison groups.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.41</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients With Emergency Room Visits After Discharge</title>
        <description>Number of emergency room visits made after initial discharge by the study (icNPT) and comparison groups.</description>
        <time_frame>Day of surgery to 30 days postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Negative Pressure Wound Therapy</title>
            <description>After standard cesarean section completed patients will have Prevena negative pressure wound therapy system placed.
Negative pressure wound therapy: Single use negative pressure wound therapy systems are composed of a pressure pump and dressing kit. The pump creates a negative pressure of 125 mmHg (+/- 20 mgHg) and the dressing directly covers surgical incision. The system is battery-powered and designed to be used for a minimum of two days and a maximum of seven days of continuous use. The investigators hypothesize that negative pressure wound therapy will decrease the wound complications in these patients. The investigators will be using Prevena Incision Management System as the negative pressure device in our study.</description>
          </group>
          <group group_id="O2">
            <title>Standard Dressing</title>
            <description>After standard cesarean section completed patients will have standard dressing placed.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With Emergency Room Visits After Discharge</title>
          <description>Number of emergency room visits made after initial discharge by the study (icNPT) and comparison groups.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="222"/>
                <count group_id="O2" value="219"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>No ER visits</title>
                  <measurement_list>
                    <measurement group_id="O1" value="190"/>
                    <measurement group_id="O2" value="190"/>
                  </measurement_list>
                </category>
                <category>
                  <title>1 ER visit</title>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                    <measurement group_id="O2" value="28"/>
                  </measurement_list>
                </category>
                <category>
                  <title>2 ER visits</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Ho: There is no difference between the number of ER visits made per person between the study (icNPT) and comparison groups.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.38</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients With Number of Clinic Visits</title>
        <description>Number of clinic visits made by patients after surgery concerning wound morbidity per patient</description>
        <time_frame>Day of surgery to 30 days postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Negative Pressure Wound Therapy</title>
            <description>After standard cesarean section completed patients will have Prevena negative pressure wound therapy system placed.
Negative pressure wound therapy: Single use negative pressure wound therapy systems are composed of a pressure pump and dressing kit. The pump creates a negative pressure of 125 mmHg (+/- 20 mgHg) and the dressing directly covers surgical incision. The system is battery-powered and designed to be used for a minimum of two days and a maximum of seven days of continuous use. The investigators hypothesize that negative pressure wound therapy will decrease the wound complications in these patients. The investigators will be using Prevena Incision Management System as the negative pressure device in our study.</description>
          </group>
          <group group_id="O2">
            <title>Standard Dressing</title>
            <description>After standard cesarean section completed patients will have standard dressing placed.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With Number of Clinic Visits</title>
          <description>Number of clinic visits made by patients after surgery concerning wound morbidity per patient</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="222"/>
                <count group_id="O2" value="219"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 visit</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 visits</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 visits</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 visits</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 visits</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.48</p_value>
            <p_value_desc>Ho: There is no difference between the number of visits made to the clinic for wound morbidity per patient between the study (icNPT) and comparison groups.</p_value_desc>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Morbid Outcomes After Delivery</title>
        <time_frame>Day of Surgery to 30 days postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Negative Pressure Wound Therapy</title>
            <description>After standard cesarean section completed patients will have Prevena negative pressure wound therapy system placed.
Negative pressure wound therapy: Single use negative pressure wound therapy systems are composed of a pressure pump and dressing kit. The pump creates a negative pressure of 125 mmHg (+/- 20 mgHg) and the dressing directly covers surgical incision. The system is battery-powered and designed to be used for a minimum of two days and a maximum of seven days of continuous use. The investigators hypothesize that negative pressure wound therapy will decrease the wound complications in these patients. The investigators will be using Prevena Incision Management System as the negative pressure device in our study.</description>
          </group>
          <group group_id="O2">
            <title>Standard Dressing</title>
            <description>After standard cesarean section completed patients will have standard dressing placed.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Morbid Outcomes After Delivery</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="222"/>
                <count group_id="O2" value="219"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Readmission</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative antimicrobials</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                    <measurement group_id="O2" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Reoperation for I and D/Extirpation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Ho: There is no difference between number of readmissions between the study (icNPT) and comparison groups.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.52</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Ho: There is no difference in the use of post operative antimicrobials between the the study (icNPT) and comparison groups.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.45</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Ho: There is no difference in the number of patients with Incision and Drainage and/or Extirpation between the study (icNPT) and comparison groups.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.44</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Scheduled and Unscheduled Cesarean Section</title>
        <description>Cochran Mantel-Hanzel measures used to compare interactions between scheduled and unscheduled cesarean sections stratified by icNPT and standard dressing, for wound morbidity</description>
        <time_frame>Day of Surgery to 30 days postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Negative Pressure Wound Therapy</title>
            <description>After standard cesarean section completed patients will have Prevena negative pressure wound therapy system placed.
Negative pressure wound therapy: Single use negative pressure wound therapy systems are composed of a pressure pump and dressing kit. The pump creates a negative pressure of 125 mmHg (+/- 20 mgHg) and the dressing directly covers surgical incision. The system is battery-powered and designed to be used for a minimum of two days and a maximum of seven days of continuous use. The investigators hypothesize that negative pressure wound therapy will decrease the wound complications in these patients. The investigators will be using Prevena Incision Management System as the negative pressure device in our study.</description>
          </group>
          <group group_id="O2">
            <title>Standard Dressing</title>
            <description>After standard cesarean section completed patients will have standard dressing placed.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Scheduled and Unscheduled Cesarean Section</title>
          <description>Cochran Mantel-Hanzel measures used to compare interactions between scheduled and unscheduled cesarean sections stratified by icNPT and standard dressing, for wound morbidity</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Scheduled</title>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unscheduled</title>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Cochran-Mantel-Haenzel test for interactions between different risk factors: scheduled vs unscheduled cesarean section and icNPT vs Standard dressing</non_inferiority_desc>
            <p_value>0.68</p_value>
            <p_value_desc>Ho: There is no difference between patients with wound morbidity that is significantly affected by the use of icNPT and whether or not the cesarean is scheduled or unscheduled.</p_value_desc>
            <method>Cochran-Mantel-Haenszel</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Pfannenstiel Versus Midline Abdominal Incisions for Cesarian Section</title>
        <description>Cochran-Mantel-Haenzel test for interactions between pfannenstiel and midline abdominal incisions stratified by icNPT vs Standard dressing, for wound morbidity</description>
        <time_frame>Day of Surgery to 30 days postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Negative Pressure Wound Therapy</title>
            <description>After standard cesarean section completed patients will have Prevena negative pressure wound therapy system placed.
Negative pressure wound therapy: Single use negative pressure wound therapy systems are composed of a pressure pump and dressing kit. The pump creates a negative pressure of 125 mmHg (+/- 20 mgHg) and the dressing directly covers surgical incision. The system is battery-powered and designed to be used for a minimum of two days and a maximum of seven days of continuous use. The investigators hypothesize that negative pressure wound therapy will decrease the wound complications in these patients. The investigators will be using Prevena Incision Management System as the negative pressure device in our study.</description>
          </group>
          <group group_id="O2">
            <title>Standard Dressing</title>
            <description>After standard cesarean section completed patients will have standard dressing placed.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Pfannenstiel Versus Midline Abdominal Incisions for Cesarian Section</title>
          <description>Cochran-Mantel-Haenzel test for interactions between pfannenstiel and midline abdominal incisions stratified by icNPT vs Standard dressing, for wound morbidity</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>pfannenstiel</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>midline</title>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Cochran-Mantel-Haenzel test for interactions between different risk factors: pfannenstiel vs midline abdominal incision and icNPT vs Standard dressing</non_inferiority_desc>
            <p_value>0.27</p_value>
            <method>Cochran-Mantel-Haenszel</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients With Ruptured and Unruptured Membranes Prior to Cesarean Section</title>
        <description>Cochran-Mantel-Haenzel measure used to compare interaction in icNPT and Standard dressing stratified by Ruptured vs Unruptured membranes</description>
        <time_frame>Day of Surgery to 30 days postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Negative Pressure Wound Therapy</title>
            <description>After standard cesarean section completed patients will have Prevena negative pressure wound therapy system placed.
Negative pressure wound therapy: Single use negative pressure wound therapy systems are composed of a pressure pump and dressing kit. The pump creates a negative pressure of 125 mmHg (+/- 20 mgHg) and the dressing directly covers surgical incision. The system is battery-powered and designed to be used for a minimum of two days and a maximum of seven days of continuous use. The investigators hypothesize that negative pressure wound therapy will decrease the wound complications in these patients. The investigators will be using Prevena Incision Management System as the negative pressure device in our study.</description>
          </group>
          <group group_id="O2">
            <title>Standard Dressing</title>
            <description>After standard cesarean section completed patients will have standard dressing placed.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With Ruptured and Unruptured Membranes Prior to Cesarean Section</title>
          <description>Cochran-Mantel-Haenzel measure used to compare interaction in icNPT and Standard dressing stratified by Ruptured vs Unruptured membranes</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Ruptured</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unruptured</title>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Cochran-Mantel-Haenzel test for interactions between different risk factors: ruptured vs unruptured membranes and icNPT vs Standard dressing</non_inferiority_desc>
            <p_value>0.55</p_value>
            <method>Cochran-Mantel-Haenszel</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients in Labor Versus no Labor Prior to Cesarean Section</title>
        <description>Cochran-Mantel-Haenzel measure used to compare interaction in icNPT and Standard dressing stratified by patients in labor and patients not in labor</description>
        <time_frame>Day of Surgery to 30 days postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Negative Pressure Wound Therapy</title>
            <description>After standard cesarean section completed patients will have Prevena negative pressure wound therapy system placed.
Negative pressure wound therapy: Single use negative pressure wound therapy systems are composed of a pressure pump and dressing kit. The pump creates a negative pressure of 125 mmHg (+/- 20 mgHg) and the dressing directly covers surgical incision. The system is battery-powered and designed to be used for a minimum of two days and a maximum of seven days of continuous use. The investigators hypothesize that negative pressure wound therapy will decrease the wound complications in these patients. The investigators will be using Prevena Incision Management System as the negative pressure device in our study.</description>
          </group>
          <group group_id="O2">
            <title>Standard Dressing</title>
            <description>After standard cesarean section completed patients will have standard dressing placed.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients in Labor Versus no Labor Prior to Cesarean Section</title>
          <description>Cochran-Mantel-Haenzel measure used to compare interaction in icNPT and Standard dressing stratified by patients in labor and patients not in labor</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Labor</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No labor</title>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Cochran-Mantel-Haenzel test for interactions between labor vs no labor stratified by icNPT vs Standard dressing</non_inferiority_desc>
            <p_value>0.49</p_value>
            <method>Cochran-Mantel-Haenszel</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients With Hypertension Versus no Hypertension</title>
        <description>Cochran-Mantel-Haenzel measure used to compare interaction between patients with hypertension versus no hypertension stratified by icNPT versus standard dressing, in wound morbidity</description>
        <time_frame>Day of Surgery to 30 days postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Negative Pressure Wound Therapy</title>
            <description>After standard cesarean section completed patients will have Prevena negative pressure wound therapy system placed.
Negative pressure wound therapy: Single use negative pressure wound therapy systems are composed of a pressure pump and dressing kit. The pump creates a negative pressure of 125 mmHg (+/- 20 mgHg) and the dressing directly covers surgical incision. The system is battery-powered and designed to be used for a minimum of two days and a maximum of seven days of continuous use. The investigators hypothesize that negative pressure wound therapy will decrease the wound complications in these patients. The investigators will be using Prevena Incision Management System as the negative pressure device in our study.</description>
          </group>
          <group group_id="O2">
            <title>Standard Dressing</title>
            <description>After standard cesarean section completed patients will have standard dressing placed.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With Hypertension Versus no Hypertension</title>
          <description>Cochran-Mantel-Haenzel measure used to compare interaction between patients with hypertension versus no hypertension stratified by icNPT versus standard dressing, in wound morbidity</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hypertension</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No Hypertension</title>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                    <measurement group_id="O2" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Cochran-Mantel-Haenzel measure used to estimate interaction between patients with hypertension versus no hypertension stratified by icNPT versus standard dressing in wound morbidity</non_inferiority_desc>
            <p_value>0.92</p_value>
            <method>Cochran-Mantel-Haenszel</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients With Insulin Requiring Diabetes Versus no Insulin Requiring Diabetes</title>
        <description>Cochran-Mantel-Haenzel measure used to compare interaction in icNPT and Standard wound dressings stratified by women with insulin requiring diabetes and no insulin requiring Diabetes.</description>
        <time_frame>Day of Surgery to 30 days postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Negative Pressure Wound Therapy</title>
            <description>After standard cesarean section completed patients will have Prevena negative pressure wound therapy system placed.
Negative pressure wound therapy: Single use negative pressure wound therapy systems are composed of a pressure pump and dressing kit. The pump creates a negative pressure of 125 mmHg (+/- 20 mgHg) and the dressing directly covers surgical incision. The system is battery-powered and designed to be used for a minimum of two days and a maximum of seven days of continuous use. The investigators hypothesize that negative pressure wound therapy will decrease the wound complications in these patients. The investigators will be using Prevena Incision Management System as the negative pressure device in our study.</description>
          </group>
          <group group_id="O2">
            <title>Standard Dressing</title>
            <description>After standard cesarean section completed patients will have standard dressing placed.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With Insulin Requiring Diabetes Versus no Insulin Requiring Diabetes</title>
          <description>Cochran-Mantel-Haenzel measure used to compare interaction in icNPT and Standard wound dressings stratified by women with insulin requiring diabetes and no insulin requiring Diabetes.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Insulin Diabetes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No Diabetes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Cochran-Mantel-Haenzel measure used to estimate interaction in icNPT and Standard wound dressings stratified by women with insulin requiring diabetes and no insulin requiring Diabetes.</non_inferiority_desc>
            <p_value>0.22</p_value>
            <method>Cochran-Mantel-Haenszel</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients With Chorioamnionitis Versus no Chorioamnionitis</title>
        <description>Cochran-Mantel-Haenzel measure used to estimate interaction between chorioamnionitis and no chorioamnionitis stratified by icNPT and standard dressing, for wound morbidity</description>
        <time_frame>Day of Surgery to 30 days postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Negative Pressure Wound Therapy</title>
            <description>After standard cesarean section completed patients will have Prevena negative pressure wound therapy system placed.
Negative pressure wound therapy: Single use negative pressure wound therapy systems are composed of a pressure pump and dressing kit. The pump creates a negative pressure of 125 mmHg (+/- 20 mgHg) and the dressing directly covers surgical incision. The system is battery-powered and designed to be used for a minimum of two days and a maximum of seven days of continuous use. The investigators hypothesize that negative pressure wound therapy will decrease the wound complications in these patients. The investigators will be using Prevena Incision Management System as the negative pressure device in our study.</description>
          </group>
          <group group_id="O2">
            <title>Standard Dressing</title>
            <description>After standard cesarean section completed patients will have standard dressing placed.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With Chorioamnionitis Versus no Chorioamnionitis</title>
          <description>Cochran-Mantel-Haenzel measure used to estimate interaction between chorioamnionitis and no chorioamnionitis stratified by icNPT and standard dressing, for wound morbidity</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>chorioamnionitis</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>no chorioamnionitis</title>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                    <measurement group_id="O2" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Cochran-Mantel-Haenzel measure used to estimate interaction between chorioamnionitis and no chorioamnionitis stratified by icNPT and standard dressing, for wound morbidity</non_inferiority_desc>
            <p_value>0.74</p_value>
            <method>Cochran-Mantel-Haenszel</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year, 8 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Negative Pressure Wound Therapy</title>
          <description>After standard cesarean section completed patients will have Prevena negative pressure wound therapy system placed.
Negative pressure wound therapy: Single use negative pressure wound therapy systems are composed of a pressure pump and dressing kit. The pump creates a negative pressure of 125 mmHg (+/- 20 mgHg) and the dressing directly covers surgical incision. The system is battery-powered and designed to be used for a minimum of two days and a maximum of seven days of continuous use. The investigators hypothesize that negative pressure wound therapy will decrease the wound complications in these patients. The investigators will be using Prevena Incision Management System as the negative pressure device in our study.</description>
        </group>
        <group group_id="E2">
          <title>Standard Dressing</title>
          <description>After standard cesarean section completed patients will have standard dressing placed.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="222"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="219"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="222"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="219"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="222"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="219"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>8. PUBLICATION AND REPORTS ON DATA; COPYRIGHTS
A. Prior to public presentation or submission to a journal, Investigator will submit for review to Company...content of any manuscript for publication, abstract, or presentation containing data and results of the Study, ...such review is for the limited purposes of ensuring that the manuscript accurately describes the Product and does not contain any Confidential lnformation...Investigator will have the unfettered right to publish.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Scott Roberts</name_or_title>
      <organization>UTSW Medical Center</organization>
      <phone>214-648-3113</phone>
      <email>scott.roberts@utsouthwestern.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

